Loading...
How deaths can help clinicians and policy‐makers understand the risks of novel psychoactive substances
Novel psychoactive substances (NPS), especially those newly created, are largely an unknown quantity, particularly in terms of their potential serious adverse effects. This means that policy‐makers and clinicians are under‐informed about appropriate responses. Collation of detailed information on de...
Saved in:
| Published in: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7080619/ https://ncbi.nlm.nih.gov/pubmed/31770457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14183 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|